Uptake from the circulation has been demonstrated site of production.
in renal interstitial fluid by some [4] , but not all [5] , and endocytosis. If so, the results indicate that most renal AT 1 investigators. High concentrations of Ang II also have receptors are exposed to locally generated Ang II rather than Ang II from the circulation. We propose the existence of a lowbeen found in proximal tubular fluid [6, 7] . Measure-Ang II vascular system-related interstitial compartment that is ments of renin in renal lymph indicated that renal interseparate from tubular fluid, where, according to micropuncture stitial fluid contains renin in high concentrations [8, 9] , studies, Ang II levels might be high. and the interstitial fluid compartment is thought to be the site of intrarenal Ang II production.
This concept needs some qualification, since in juxta-Intrarenal angiotensin II (Ang II) has important efglomerular cells, renin, angiotensinogen and Ang I and fects on renal function and urinary sodium excretion and, Ang II are co-localized in secretory granules [10] [11] [12] . via these local actions, on blood pressure regulation. The Ang I and probably also Ang II are co-secreted with presence of Ang II in renal tissue depends on two mecharenin by these cells [10] [11] [12] . The detection of high levels nisms: uptake from the circulation and local production.
of Ang II in renal interstitial fluid may be viewed as evidence supporting the functional significance of locally much is produced locally, and (2) to collect information of 125 I-Ang I as described before [15] . Plasma was stored at Ϫ70ЊC and assayed within three days. on the site of intrarenal Ang II production and on its Renal tissue samples were collected as follows. The distribution over the interstitial fluid and cell compartheart was stopped by fibrillation while the 125 I-Ang I ments. Our approach was to measure the concentrations infusion was still running. The abdomen was opened by of endogenous Ang I and II in conjunction with measurea longitudinal incision and both kidneys were rapidly ments of 125 I-Ang I and II in renal cortical and medullary dissected. Pieces of renal cortex and medulla (1 to 2 g) tissue from pigs receiving a systemic infusion of 125 Iwere immediately frozen in liquid nitrogen and stored Ang I. Studies were performed in untreated animals and at Ϫ70ЊC. after treatment with an ACE inhibitor or AT 1 receptor antagonist. The rationale for using these drugs as investi-Measurement of angiotensins gative tools lies in the fact that they act at different 125 I-labeled and endogenous Ang I and Ang II were levels of the renin-angiotensin system, and may therefore measured as described previously [1, 16, 17] , using Sepdifferentially affect the uptake, production and compart-Pak extraction and high-performance liquid chromamentalization of Ang II in the kidney. tography (HPLC) separation. The concentrations of 125 Ilabeled and endogenous angiotensins were not corrected for losses occurring during extraction and separation METHODS (ϳ20 to 30% in whole tissue homogenates and Ͻ10% in Animals plasma [1, 16, 17] ). For Ang I, the lower limit of detection All experiments were carried out under the regulawas 0.5 fmol/mL of plasma and 1 fmol/g of tissue. For tions of the Animal Care Committee of the Erasmus Ang II, the lower limit of detection was 0.3 fmol/mL of University Rotterdam, Rotterdam, The Netherlands, in plasma and 0.5 fmol/g of tissue. accordance with the Guide for the Care and Use of Labo-Calculations ratory Animals as published by the U.S. National Institutes of Health. Twenty-one two-to three-month-old
In a previous study [1] we observed that the renal Yorkshire ϫ Landrace pigs (weight 25 to 30 kg) of either tissue/arterial plasma concentration ratio of 125 I-Ang II during 125 I-Ang I infusion was not higher than during sex were included in the study. In all animals a suture 125 I-Ang II infusion. Thus, the 125 I-Ang II that was present was placed around the left circumflex coronary artery in renal tissue was derived from arterially delivered (LCXCA) in order to examine the effect of coronary 125 I-Ang II and not, via conversion, from arterially delivligation on the cardiac levels of Ang II in these animals ered 125 I-Ang I. The renal tissue level of Ang II (fmol/g) [14] . The LCXCA was permanently ligated in 16 animals, that originates from angiotensin in the circulation was whereas the suture was removed in five animals (sham therefore calculated as follows: operation). Of the permanently ligated animals, five received captopril (25 mg b.i.d.), and five animals received [Ang II tissue ] originating from circulation the AT 1 (cpm/g) and arterial plasma (cpm/mL), respectively. were prepared for administration of anesthetic and 125 I-Ang I and for blood and tissue sampling as described Data analysis previously [1] . After a stabilization period of 30 to 45 Data are expressed as mean Ϯ SEM. Differences beminutes following completion of instrumentation, anitween treated and untreated animals were tested by mals were subjected to a one-hour infusion of 125 I-Ang I ANOVA. Statistical significance was accepted at P Ͻ 0.05. (Ϸ1.5 ϫ 10 6 cpm/min) into the left ventricle. 125 I-Ang I and II reach steady-state levels in plasma within ten RESULTS minutes, and in renal tissue within 60 minutes [1, 15] .
Uptake of angiotensin II from blood versus Collection of blood and tissue samples local production and contribution to tissue angiotensin II levels To measure the plasma levels of 125 I-labeled and endogenous Ang I and II, blood samples (5 to 10 mL) were Figure 1 shows an example of high pressure liquid chromatography (HPLC) separation patterns of 125 I-labeled taken from the aorta and a renal vein during the infusion (N ϭ 5). Data for the two groups were therefore com-In control animals (that is, animals that were not treated with captopril or eprosartan), coronary ligation did not bined. In the combined control group, the levels of en- dogenous Ang I in cortical and medullary tissue were similar (Fig. 2 ), and the same applies to the levels of endogenous Ang II at these sites ( Fig. 3) .
in arterial plasma also was lower in the captopril-treated animals than in controls (0.17 Ϯ 0.04 vs. 0.54 Ϯ 0.08; 125 I-Ang I was not detectable in tissue (Fig. 1 ). In contrast, the tissue concentration of endogenous Ang I was P Ͻ 0.01). 125 I-Ang I was undetectable in tissue after captopril, as was the case in controls. much higher than the concentration in arterial plasma (Table 1) . Thus, virtually all tissue Ang I appears to
The Ang II/I concentration ratios in cortical tissue were not significantly different in captopril-treated ani-originate from local production in the kidney.
The concentration of 125 I-Ang II in cortical tissue was mals and controls (1.80 Ϯ 0.19 and 2.27 Ϯ 0.47, respectively). This was also true for the Ang II/I concentration four times the concentration in arterial plasma, and the cortical tissue concentration of endogenous Ang II was ratios in medullary tissue (1.29 Ϯ 0.18 and 2.00 Ϯ 0.66, respectively). In the captopril group, as in controls, most 100 times the concentration in arterial plasma ( Table 2) . The 125 I-Ang II concentration in medullary tissue was tissue Ang II appears to be derived from local production, and not from the circulation (Fig. 3) . two times the concentration in arterial plasma, and endogenous Ang II in medullary tissue was 60 times higher
The 125 I-Ang II/I concentration ratio in arterial plasma was 0.73 Ϯ 0.09 in the eprosartan-treated animals (N ϭ than in arterial plasma. Thus, the tissue/blood plasma 5), which was not different from the ratio in controls. concentration ratio was much higher for endogenous
The endogenous Ang II/I concentration ratio in arterial Ang II than it was for 125 I-Ang II. These results show plasma in the eprosartan-treated animals was 0.92 Ϯ 0.09, that about 85% of tissue Ang II originated from local which was also not different from the ratio in controls. production by the kidney (Fig. 3) . 125 I-Ang I was undetectable both in cortical and medul-Only 10 to 15% of arterially delivered 125 I-Ang I lary tissue in the eprosartan-treated animals, as was the reached the renal vein, and the same was true for case in the captopril group and in controls. In the epro-125 I-Ang II (Tables 1 and 2 ). The concentration of endogsartan group, as in the captopril group and in controls, enous Ang I in renal venous plasma was not different most tissue Ang II appears to be derived from local from that in arterial plasma (Table 1) . Therefore, it approduction and not from the circulation (Fig. 3 ). pears that 85 to 90% of renal venous Ang I originates In the captopril group, the cortical tissue concentration from production within the kidney. No such release from of 125 I-Ang II was about five times the concentration in arrenal tissue sites could be demonstrated for Ang II, since terial plasma, which was not significantly different from the renal venous/arterial plasma concentration ratio of the cortical tissue/arterial plasma 125 I-Ang II concentraendogenous Ang II was as low as that of 125 I-Ang II tion ratio in controls ( Table 2 ). In the eprosartan group, (Table 2) .
the cortical tissue concentration of 125 I-Ang II was only Effects of captopril and eprosartan 0.4 times the concentration in arterial plasma. A similar difference between the eprosartan group on the one Captopril lowered the 125 I-Ang II/I ratio in arterial plasma. It was 0.17 Ϯ 0.03 (N ϭ 5) in the captopril-hand and the captopril and control groups on the other was seen for the medullary tissue concentrations of 125 I-treated animals, as compared to 0.53 Ϯ 0.05 (N ϭ 11) in controls (P Ͻ 0.01). The endogenous Ang II/I ratio Ang II. These results demonstrate that the accumulation of blood-derived Ang II in tissue is mediated by AT 1 conclusion that the bulk of Ang II in the kidney is formed locally by conversion of locally produced Ang I and is receptors.
The renal venous/arterial plasma concentration ratios not derived from Ang I or II in the circulation.
Our results provide some information on the distribu-of both 125 I-Ang I and 125 I-Ang II in the animals treated with captopril and eprosartan were comparable to the tion of Ang II in the extracellular and cell compartments of renal tissue. In this context, one has to consider the ratios in controls, and the same was true for endogenous Ang I (Tables 1 and 2) . The renal venous/arterial plasma possibility that blood-derived Ang II does not enter all regions of the kidney. For the sake of simplicity, we concentration ratio of endogenous Ang II in the captopril group tended to be higher than in the other groups, consider a region that is reached by blood-derived Ang II and a region that is not reached by blood-derived Ang II. but the difference did not reach statistical significance. Our results in the captopril and eprosartan groups were
The present study showed a 90% reduction of the tissue/ arterial plasma 125 I-Ang II concentration ratio after epro-therefore similar to those in controls, in that these results provided evidence for the release of Ang I, but not sartan. If it is assumed that after the AT 1 receptors had been blocked by eprosartan, all 125 I-Ang II in tissue was Ang II, from renal tissue into the circulation. localized in extracellular fluid, our results would imply that, in the absence of AT 1 receptor blockade, 10% of DISCUSSION 125 I-Ang II in the kidney, in the region in which blood-Intrarenal Ang II has important functions in regulating derived Ang II is distributed, is localized in extracellular urine flow, urinary sodium excretion and glomerular filfluid and 90% is cell-associated. Most likely, however, tration rate. It has a major role in the pathogenesis of AT 1 receptor blockade by eprosartan was not complete.
2-kidney, 1 clip (2K1C) hypertension and possibly also
If our finding that the tissue/arterial plasma 125 I-Ang II in the hypertension of the spontaneously hypertensive concentration ratio was reduced by 90% after eprosartan rat [2, 3, 18, 19] . Although renin is suppressed in the would be the consequence of 90% AT 1 receptor occucontralateral non-clipped kidney of 2K1C hypertensive pancy by this drug, then 100% occupancy would result rats and in the remaining kidney of uninephrectomized in a tissue/arterial plasma 125 I-Ang II concentration ratio rats during chronic low dose Ang II infusion, Ang II in of zero, which would mean that, in the absence of AT 1 the kidneys is increased to levels that are too high to be receptor blockade, virtually all 125 I-Ang II in the kidney explained by passive diffusion from circulation to tissue is cell-associated. [18] . Studies using AT 1 receptor antagonists provided That AT 1 receptor blockade after eprosartan was instrong evidence to support that tissue Ang II in the deed not complete, was indicated by earlier experiments non-clipped kidney contributes to the pathogenesis of in which we measured the steady-state levels of 125 Isystemic hypertension by reducing renal function and Ang II in subcellular fractions of renal cortical tissue sodium excretion [19] . AT 1 receptor-mediated uptake from pigs receiving systemic infusions of 125 I-Ang I or II and accumulation of Ang II from the circulation could [20] . Not only in control animals, but also in animals be one of the mechanisms by which intrarenal Ang II is treated with the same doses of eprosartan as used in the maintained even when renin is suppressed [1] [2] [3] . Anpresent study, 125 I-Ang II was found to be concentrated other possibility is the existence of a positive feedback in the nuclear, lysosomal and microsomal cell fractions. loop by which intrarenal Ang II formation is enhanced
In the eprosartan-treated animals, 70% of the total after AT 1 receptor stimulation [2, 3] . amount of 125 I-Ang II in the combined cell fractions was The present study in pigs shows that, normally, most found in the nuclear, lysosomal and microsomal fractions Ang II in the kidney is not derived from the circulation, with less than 20% loss of 125 I-Ang II during preparation but is produced locally. We found that AT 1 receptorof these fractions. These results indicate that AT 1 recepmediated binding and accumulation of 125 I-Ang II from tor blockade was not complete and that indeed nearly the circulation led to a tissue level four times the level all blood-derived Ang II in renal cortical tissue is cellin arterial plasma, whereas the tissue level of endogenous associated. Ang II was 100 times the level in arterial plasma.
It is commonly held that tissue Ang II is produced in 125 I-Ang I from the circulation was not accumulated. Its the extracellular interstitial fluid compartment. Extraceltissue level was at or below the detection limit, whereas lular Ang II is then bound to cell surface AT 1 receptors endogenous Ang I in tissue was much higher than in and internalized. If this view is correct, our results imply arterial plasma. A previous study, in which we compared that most renal AT 1 receptors are exposed to locally the results after 125 I-Ang I infusion with those after produced Ang II rather than Ang II from the circulation. 125 I-Ang II infusion, has shown that the 125 I-Ang II that Following this line of reasoning, we propose that the high was found in renal tissue was derived from arterially tissue/arterial plasma concentration ratio of endogenous delivered 125 I-Ang II and not from arterially delivered Ang II, as observed in the present study, depends on the same mechanism as has been demonstrated for 125 I-125 I-Ang I [1] . Taken together, our results lead to the Ang II, that is, AT 1 receptor-mediated binding to cells not decreased by this drug. Thus, neither the decrease in AT 1 receptor-mediated uptake nor a negative effect followed by internalization. The concept that receptormediated binding and endocytosis are instrumental in on intrarenal Ang II formation caused by interruption of a supposedly positive AT 1 receptor-dependent feedback maintaining a low Ang II concentration in interstitial fluid also is supported by our finding that 85 to 90% of loop [2, 3] had led to a decrease in tissue Ang II after Ang I in renal venous plasma had been produced within eprosartan administration. This might be explained, at the kidney, whereas no significant release of Ang II from least in part, by the stimulation of renin following AT 1 the kidney into the circulation could be demonstrated.
receptor blockade. Such stimulation causes enhanced Similar observations were made in humans [21, 22] .
Ang II generation in extracellular fluid, as reflected by This concept, however, seems to be at variance with increased plasma Ang II (Fig. 3) . The decrease in the a study in which Ang II was measured in renal interstitial tissue/arterial plasma concentration ratio of endogenous fluid from rats using a microdialysis technique [4] . In Ang II after eprosartan was similar to the decrease in the that study the Ang II concentration in interstitial fluid tissue/arterial plasma concentration ratio of 125 I-Ang II was found to be 1000 to 10,000 times the concentration ( Table 2) , which is in agreement with the concept that in plasma. How can this discrepancy be explained? Siragy endogenous Ang II, like 125 I-Ang II, enters the cells via et al measured so-called immunoreactive Ang II-like AT 1 receptor-mediated endocytosis. However, because material [4] , whereas we measured HPLC-purified Ang of the eprosartan-induced rise in extracellular Ang II, II. However, it is unlikely that this is sufficient explanathe kidney is capable of maintaining its high intracellular tion. A more fundamental problem could be the microdi-Ang II levels despite the AT 1 receptor blockade. An alysis technique itself. In order to perform microdialysis additional explanation for the absence of eprosartanexperiments, a dialysis membrane probe has to be ininduced reductions in renal Ang II could be that changes serted into the tissue. The probe used by Siragy et al in Ang II concentration in whole tissue do not reliably had an internal diameter of 0.3 mm [4] . The presence of reflect the changes that might occur at the level of AT 1 this probe alters the micro-environment of the surreceptors in the tissue region in which blood-derived rounding cells. Normally, the water space between the Ang II is distributed. In our study renal tissue Ang II also cells is very small. Considering a model of two parallel was not reduced by treatment with the ACE inhibitor cell layers 1 m apart, insertion of a cylindrical probe captopril in doses that were high enough to suppress the of 0.3 mm diameter between the two layers will increase Ang II/I concentration ratio in blood. It is tempting to the extracellular space separating the cells by a factor invoke alternative pathways of Ang I-II conversion. of about 150 (cross-sectional area of cylinder divided by Other explanations however, like those mentioned above the product of half cylinder circumference and normal with respect to the effects of eprosartan, cannot be exdistance between cell layers). As a consequence, the cell cluded. surface receptors facing the probe are bathed in a much Micropuncture experiments showed high levels of larger volume of water than normal. The binding of Ang II in proximal tubular fluid from rats [6, 7] . There Ang II to its receptors, therefore, takes place at an artifiis further evidence in the rat that interstitial cells, located cially low receptor concentration. If normally the in vivo in the inner stripe of the outer renal medulla, are exposed binding of Ang II takes place at receptor concentrations to high interstitial Ang II concentrations [23, 24] . When that are higher than the equilibrium dissociation constant these observations are incorporated into our results, a (K d ), so that most Ang II is complexed with the receptors, picture emerges in which the renal interstitium contains a 150-fold reduction in receptor density may lead to a a low-Ang II vascular system-related compartment, and new steady state with a big increase in free Ang II. It is a high-Ang II tubular system-related compartment. The therefore possible that the high Ang II level, as measured juxtaglomerular cells, as part of the vascular compartwith the microdialysis technique, is an artifact. ment, are in close anatomical relationship with the mac-Our proposal that the high AT 1 receptor density in ula densa cells that are part of the tubular compartment. the kidney is responsible for a low Ang II concentration These cells are therefore strategically situated to serve in interstitial fluid has important implications. It means communication between the two compartments. there is no need for postulating a blood/interstitium 'barrier' preventing in situ produced Ang II from leaking ACKNOWLEDGMENT into the blood. It also resolves the conflict between the
